Gregory Norden Royalty Pharma PLC (RPRX) insider trading activity

RPRX Quotes by TradingView

Gregory Norden is Director of Royalty Pharma plc. Currently has a direct ownership of 73,738 shares of RPRX, which is worth approximately $1.87 Million. The most recent transaction as insider was on Jun 07, 2024, when has been sold 9,293 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.7K
0% 3M change
14.42% 12M change
Total Value Held $1.87 Million

Gregory Norden Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2024
BUY
Grant, award, or other acquisition
-
9,293 Added 11.19%
73,738 Class A Ordinary Shares
Jun 23 2023
BUY
Grant, award, or other acquisition
-
7,747 Added 10.73%
64,445 Class A Ordinary Shares
Jun 24 2022
BUY
Grant, award, or other acquisition
-
6,328 Added 10.04%
56,698 Class A Ordinary Shares
Jun 25 2021
BUY
Grant, award, or other acquisition
-
5,726 Added 10.21%
50,370 Class A Ordinary Shares

Also insider at

NSTG
NanoString Technologies Inc Healthcare
Director
ZTS
Zoetis Inc. Healthcare
Director
PRAX
Praxis Precision Medicines, Inc. Healthcare
Director
GN

Gregory Norden

Director
Parsippany, NJ

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPRX